Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 556.00
+2.00 (0.36%)
At close: Feb 6, 2026
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 22.58 billion as of February 6, 2026. Its market cap has increased by 17.55% in one year.
Market Cap
22.58B
Enterprise Value
19.24B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
556.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 22.58B, an increase of 276.80%. That is a compound annual growth rate of 7.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 22.50B | -10.93% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 26.14B |
| AnGes | 22.95B |
| Renascience | 19.28B |
| StemRIM | 17.61B |
| CanBas | 17.37B |
| ReproCELL | 15.06B |
| Immuno-Biological Laboratories | 14.11B |
| Kubota Pharmaceutical Holdings | 12.69B |